Gliddon C M, Sansom A J, Smith P F, Darlington C L
Department of Pharmacology, School of Medical Sciences, University of Otago Medical School, Dunedin, New Zealand.
Exp Brain Res. 2000 Sep;134(1):74-80. doi: 10.1007/s002210000437.
Removal of the peripheral vestibular receptor cells in one inner ear (unilateral vestibular deafferentation, UVD) results in a syndrome of ocular motor and postural disorders, many of which disappear over time in a process of behavioural recovery known as vestibular compensation. Excitatory amino acid receptors, in particular the N-methyl-D-aspartate (NMDA) receptor, have been implicated in vestibular compensation; however, the metabotropic glutamate receptors (mGluRs) have not been studied in this context. The aim of this study was to determine whether group I mGluRs in the brainstem vestibular nucleus complex (VNC) ipsilateral to the UVD are involved in vestibular compensation of the static symptoms of UVD in guinea pig. The selective group I mGluR antagonist (RS)-1-aminoindan-1,5,dicarboxylic acid (AIDA) was continuously infused into the ipsilateral VNC for 30-min pre-UVD and 30-min post-UVD by cannula, at a rate of 1 microl/h, using one of four doses: 0.1 fg, 0.1 pg, 0.1 ng or 0.1 microg (n=5 animals in each case). In control conditions, a 0.1-fg (n=4) or 0.1-microg (n=5) NaOH vehicle was infused into the ipsilateral VNC using the same protocol. In order to control for the possibility that AIDA disrupted spontaneous neuronal activity in the VNC in normal animals, 0.1 microg AIDA (n=4) or 0.1 microg NaOH (n=2) was infused into the VNC in labyrinthine-intact animals. In both groups, static symptoms of UVD (i.e. spontaneous nystagmus, SN, yaw head tilt, YHT and roll head tilt, RHT) were measured at 8, 10, 12, 15, 20, 25, 30, 35, 45 and 50 h post-UVD. In addition, the righting reflex latency (RRL) was measured in labyrinthine-intact animals in order to assess whether AIDA impaired motor coordination in labyrinthine-intact animals. In UVD animals, the highest dose of AIDA significantly reduced SN frequency and changed its rate of compensation (P<0.001 and P<0.0001, respectively). This dose of AIDA also caused a significant reduction in YHT (P<0.005) as well as a significant change in its rate of compensation (P<0.0001). However, RHT was not significantly affected. In the labyrinthine-intact animals, AIDA infusion did not induce a UVD syndrome, nor did it significantly affect RRL. These results suggest that group I mGluRs in the ipsilateral VNC may be involved in the expression of ocular motor and some postural symptoms following UVD. Furthermore, group I mGluRs may not contribute to the resting activity of vestibular nucleus neurons.
切除一侧内耳的外周前庭感受器细胞(单侧前庭去传入,UVD)会导致一系列眼动和姿势障碍综合征,其中许多症状会随着时间的推移在一个称为前庭代偿的行为恢复过程中消失。兴奋性氨基酸受体,特别是N-甲基-D-天冬氨酸(NMDA)受体,与前庭代偿有关;然而,代谢型谷氨酸受体(mGluRs)在这方面尚未得到研究。本研究的目的是确定UVD同侧脑干前庭核复合体(VNC)中的I组mGluRs是否参与豚鼠UVD静态症状的前庭代偿。通过套管以1微升/小时的速率将选择性I组mGluR拮抗剂(RS)-1-氨基茚满-1,5-二羧酸(AIDA)连续注入同侧VNC,在UVD前30分钟和UVD后30分钟,使用四种剂量之一:0.1飞克、0.1皮克、0.1纳克或0.1微克(每种情况n = 5只动物)。在对照条件下,使用相同方案将0.1飞克(n = 4)或0.1微克(n = 5)的NaOH载体注入同侧VNC。为了控制AIDA破坏正常动物VNC中自发神经元活动的可能性,将0.1微克AIDA(n = 4)或0.1微克NaOH(n = 2)注入内耳完整动物的VNC。在两组中,在UVD后8、10、12、15、20、25、30、35、45和50小时测量UVD的静态症状(即自发性眼球震颤,SN,偏航性头部倾斜,YHT和侧滚性头部倾斜,RHT)。此外,在内耳完整的动物中测量翻正反射潜伏期(RRL),以评估AIDA是否损害内耳完整动物的运动协调性。在UVD动物中,最高剂量的AIDA显著降低了SN频率并改变了其代偿率(分别为P < 0.001和P < 0.0001)。该剂量的AIDA还导致YHT显著降低(P < 0.005)以及其代偿率显著变化(P < 0.